API Material Velpatasvir Powder Anticancer Velpatasvir

Still deciding? Get samples of $ !
Request Sample

Product Description

Basic Information
Model NO.
Velpatasvir
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Powder
Purity
>99%
CAS
1377049-84-7
MF
C49H54N8O8
MW
883.0
Application
Pharmaceutical
Appearance
White Powder
Production Capacity
1500kg/Month
Test Method
HPLC
Product Description
API Material Velpatasvir Powder
Vepatasvir (CAS number 1377049-84-7) is an efficient, pan genotypic inhibitor of the hepatitis C virus (HCV) NS5A replication complex. As a direct antiviral drug (DAA), its chemical structure has been optimized and it has a high affinity for HCV NS5A protein.

This product is typically formulated in a fixed dose combination with another DAA, Sofosbuvir. The synthesis process of Vepatasvir is complex, with extremely strict requirements for purity, crystal form, and related substance control, making it a key raw material for ensuring the safety and effectiveness of the final drug.

Velpatasvir Feature 1
Velpatasvir Feature 2
Product Details
Product Specification Header
Product Name Velpatasvir
Appearance White to off-white powder
CAS No. 1377049-84-7
MF C49H54N8O8
MW 883.002
Application & Function

The main function of Vepatasvir is to inhibit the function of HCV NS5A protein, which is crucial for the replication of viral RNA and the assembly of viral particles. By tightly binding to NS5A, Vepatasvir can effectively disrupt the formation of HCV replication complexes, thereby strongly inhibiting virus replication.

Key Advantage: Pan-genotypic activity. It exhibits strong antiviral effects against HCV genotypes 1 to 6. This enables therapies to simplify the treatment plan for hepatitis C without the need for complex genotyping.
Application 1
Application 2
Certificate of Analysis
Certificate of Analysis
Gallery 1
Gallery 2
Gallery 3
Gallery 4
Gallery 5
Gallery 6
Gallery 7
Gallery 8
Frequently Asked Questions
What is Velpatasvir mainly used for?
Velpatasvir is a potent inhibitor used primarily in the treatment of chronic hepatitis C virus (HCV) infection. It works by blocking the NS5A protein required for the virus to multiply.
Is Velpatasvir effective against all genotypes of Hepatitis C?
Yes, it is a pan-genotypic inhibitor, meaning it is effective against all major HCV genotypes (1 through 6).
What is the purity and quality standard of this powder?
Our Velpatasvir powder maintains a purity level of >99% and complies with GMP, ISO 9001, and international pharmacopoeia standards like USP and BP.
What are the storage and physical characteristics?
Velpatasvir is provided in a white to off-white powder form. It should be stored according to pharmaceutical standards to maintain its stability and efficacy.
Can Velpatasvir be used alone for treatment?
It is typically used as an API in fixed-dose combinations, most commonly with Sofosbuvir, to provide a complete antiviral therapy regimen.
What is the production capacity for this API material?
We have a stable production capacity of approximately 1500kg per month to meet pharmaceutical manufacturing needs.

Related Products